moxifloxacin has been researched along with Ocular Tuberculosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Agarwal, M; Dhawan, A; Gupta, C; Jha, V; Mohan, KV; Upadhyay, PK | 1 |
Gracia García-Miguel, MT; Pérez-Jacoiste, MA; Reche-Sainz, JA | 1 |
Agrawal, R; Barraclough, C; Pavesio, CE; Potter, J; Rahman, F; Westcott, M; White, V | 1 |
3 other study(ies) available for moxifloxacin and Ocular Tuberculosis
Article | Year |
---|---|
Adjunctive Intravitreal Anti-vascular Endothelial Growth Factor and Moxifloxacin Therapy in Management of Intraocular Tubercular Granulomas.
Topics: Angiogenesis Inhibitors; Bevacizumab; Fluorescein Angiography; Granuloma; Humans; Intravitreal Injections; Moxifloxacin; Ranibizumab; Tomography, Optical Coherence; Tuberculosis, Ocular; Vascular Endothelial Growth Factor A | 2023 |
Papillitis and neuroretinitis of tuberculous etiology.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Moxifloxacin; Papilledema; Prednisone; Retinitis; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular | 2019 |
Moxifloxacin: An Alternative to Ethambutol for the Treatment of Presumed Ocular Tuberculosis.
Topics: Administration, Oral; Adult; Aged; Antitubercular Agents; Complementary Therapies; Ethambutol; Female; Fluoroquinolones; Glucocorticoids; Humans; Immunosuppressive Agents; Interferons; Male; Middle Aged; Moxifloxacin; Tuberculin Test; Tuberculosis, Ocular; Young Adult | 2016 |